|Articles|June 15, 2015
Comprehend Systems Launches ClinOps Solution
Comprehend Systems, a clinical software solutions provider, announced the launch of Continuous Quality for ClinOps.
Advertisement
Comprehend Systems, a clinical software solutions provider, announced the launch of Continuous Quality for ClinOps, a solution that enables clinical operations to unify and analyze its data and automates alerts and collaboration across executives, teams and contract research organizations (CROs).
The solution automates the continuous quality lifecycle, features include:
- Analytics and Visualizations inform your decision-making and collaboration processes on site and operational performance, safety, efficacy and compliance
- Filtering enables end users to remove redundant or unwanted data from the info stream to facilitate exploration and cohort analysis
- Click-through enables the user to broaden or narrow their exploration from portfolio views down to granular study data even with unique data models across studies
- Forecasts for key indicators that predict future outcomes based on historic facts
- Cross Study Benchmarking uses current similar and past trials to inform decisions on current trials
- Monitoring system tracks trends and allows user-driven thresholds to raise events in the system. Early warnings enable ClinOps leaders to take preventative action
- Collaboration provides decentralized users with simultaneous views of analytics and ability to create data-driven tasks and workflows
- Alerts and Notifications of events can be in app or email or both
- Audit trails allows full auditability of system state from any point in time, including user activity for compliance and report configuration for decision history
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
- Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients
September 12th 2025
- Latest NIMBLE Study Results Highlight Progress in gMG Research
September 12th 2025
- ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
September 11th 2025
Advertisement
Advertisement